Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
50 participants
OBSERVATIONAL
2025-09-01
2025-11-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In this context, an individual's emotional regulation strategies play a crucial role in understanding the pain experience. Emotional suppression, in particular, is defined as the conscious suppression or inability to express one's emotions. This strategy has been reported to be associated with increased psychological stress, anxiety, depression, and pain sensitivity in the long term. Individuals who suppress their emotions have been shown to perceive pain as more threatening and develop more negative coping strategies.
Furthermore, cognitive tendencies such as pain catastrophizing, combined with emotional suppression, appear to increase an individual's psychological response to pain, impacting both pain intensity and psychological pain sensitivity. Such negative emotional regulation strategies can lead to increased pain perception and avoidance of physical activity, resulting in decreased physical performance.
Physical performance in older individuals is one of the key indicators determining their level of independence and quality of life. Tests such as the Timed Up and Go Test, the 6-Minute Walk Test, and the 30-Second Sit-to-Stand Test are widely used to assess mobility, balance, lower extremity endurance, and overall physical fitness. Chronic pain and its accompanying emotional factors are known to negatively impact physical performance.
However, studies examining the combined effects of emotional suppression on both pain perception and physical performance in older individuals are quite limited. This study contributes to the literature by offering a holistic assessment perspective by considering the physiological consequences of emotional regulation strategies in a multidimensional manner. Addressing the psychological and physical health of older individuals in conjunction is crucial for developing effective intervention programs. In this respect, the aim of the study was to examine the effect of the level of emotional suppression on pain perception (intensity and catastrophizing) and physical performance in elderly individuals.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Kinesiophobia and Physical Function in Elderly With Musculoskeletal Pain
NCT07272876
Investigation of the Relationship of Pain Perception and Pain Belief With Age in People With Chronic Lack Pain
NCT05997368
Pain Education Added to Conventional Physiotherapy Program for Patients With Neck Pain
NCT05210257
The Relationship Between Pain Perception, Severity of Temporomandibular Joint Dysfunction, and Spinal Health in Geriatric Individuals
NCT06053008
Pain Perception and Exercise-Induced Hypoalgesia Across Circadian Rhythms
NCT07290465
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Individuals over 65 years of age who can independently carry out daily living activities and whose cognitive level is sufficient to understand and answer the surveys and tests in the study.
Assessment
The group to be evaluated is comprised of individuals over 65 years of age, who can independently carry out their daily living activities, and whose cognitive level is sufficient to understand and answer the surveys and tests in the study.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Assessment
The group to be evaluated is comprised of individuals over 65 years of age, who can independently carry out their daily living activities, and whose cognitive level is sufficient to understand and answer the surveys and tests in the study.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Individuals who can independently carry out their daily living activities,
* Those with a cognitive level sufficient to understand and answer the surveys and tests in the study (Mini-Mental State Examination \[MMSE\] ≥ 24),
* Individuals who voluntarily agree to participate in the study and sign the informed consent form.
Exclusion Criteria
* Those with a history of acute injury, trauma, or surgery (within the last 6 months) that could affect pain perception or physical performance;
* Those who regularly use opioids or strong analgesic medications for pain;
* Individuals who are unable to complete assessment tests due to profound hearing or vision loss;
* Individuals diagnosed with severe depression and/or receiving active psychotherapy/psychiatric treatment;
* Individuals with physical or cognitive limitations that prevent them from completing surveys and performance tests.
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istinye University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kubra Koce
Asst. Prof.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istinye University
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025/231
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.